Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd (SHE:000766)

China flag China · Delayed Price · Currency is CNY
20.34
-0.16 (-0.78%)
May 30, 2025, 3:04 PM CST
28.01%
Market Cap 19.66B
Revenue (ttm) 1.33B
Net Income (ttm) 58.83M
Shares Out 966.49M
EPS (ttm) 0.06
PE Ratio 334.14
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 15,431,500
Average Volume 27,754,643
Open 20.56
Previous Close 20.50
Day's Range 20.26 - 20.64
52-Week Range 12.66 - 20.85
Beta 0.21
RSI 64.38
Earnings Date Aug 21, 2025

About SHE:000766

Tonghua Golden-Horse Pharmaceutical Industry Co,Ltd., together with its subsidiaries, engages in the research, development, manufacture, and sale of pharmaceutical products in China. Its products covers anti-tumor, microbial, cardiovascular, heat-clearing and detoxification, digestive system, skeletal muscle system, gynecological system, nervous system, and other fields. The company also provides bone peptides, protective chemical medicines, cardiovascular and cerebrovascular chinese patent medicines, heat-clearing and detoxifying medicines, an... [Read more]

Sector Healthcare
Founded 1990
Employees 1,532
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 000766
Full Company Profile

Financial Performance

In 2024, SHE:000766's revenue was 1.32 billion, a decrease of -10.23% compared to the previous year's 1.47 billion. Earnings were 56.44 million, an increase of 28.46%.

Financial Statements

News

There is no news available yet.